It's time to follow Prime!
In 2022, Prime Therapeutics acquired Magellan Rx to offer next-generation pharmacy benefit management solutions and a truly differentiated experience while doing what’s right for everyone we serve.
Over the next few weeks, we will be dimming the lights on our MRx channels as we officially migrate to the Prime Therapeutics brand.
We look forward to you joining us and following along at Prime Therapeutics.